Colorectal carcinoma (CRC) complicating ulcerative colitis (UC) was first recognized in 1925
by Crohn and Rosenberg, 1 but it was not until 1948 that Warren and Sommers reported …

The prevalence of inflammatory bowel disease (IBD) in patients with PSC differs in various
part of the world. Ulcerative colitis (UC) is most common, but 1 to 14% of all primary …

Background: Published data on the risk of colorectal neoplasia in patients with ulcerative
colitis with and without primary sclerosing cholangitis are conflicting. A meta-analysis was …

Diseases involving the hepatopancreatobiliary (HPB) system are frequently encountered in
patients with inflammatory bowel disease (IBD). Hepatobiliary manifestations constitute …

Few studies have examined causes of death in long-term survivors of orthotopic liver
transplantation (OLT). We reviewed causes of death among 299 adult liver transplant …

Abnormal liver biochemical tests are present in up to 30% of patients with inflammatory
bowel disease (IBD), and therefore become a diagnostic challenge. Liver and biliary tract …

OBJECTIVE: Recent studies have implicated primary sclerosing cholangitis (PSC) as a risk
factor for colorectal cancer (CRC) in ulcerative colitis (UC). Our study was designed to define …

Inflammatory bowel diseases are associated with various hepatobiliary disorders, reported
both in Crohn's disease and ulcerative colitis. They may occur at any moment in the natural …

Abstract Key Points 1 Recurrent and de novo malignancies are the second leading causes
of late death in liver transplant recipients, following age‐related cardiovascular …

Primary sclerosing cholangitis (PSC) is a chronic progressive disorder of unknown aetiology
characterised by chronic inflammation and stricture formation of the biliary tree. Symptoms …